Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
March 08 2024 - 4:05PM
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global
biopharmaceutical company developing novel oral small molecule
therapeutics for metabolic and cardiopulmonary diseases, today
announced that Raymond Stevens, Ph.D., the Company’s Founder and
Chief Executive Officer, will participate in a fireside chat at the
Leerink Partners Global Biopharma Conference on Wednesday, March
13, 2024, at 8:00 AM ET in Miami, Florida.
The live and archived webcast of the presentation will be
accessible from the company’s website
https://ir.structuretx.com/events-presentations/events. The replay
of the webcast will be available for 90 days.
About Structure TherapeuticsStructure
Therapeutics is a leading clinical-stage biopharmaceutical company
focused on discovering and developing innovative oral treatments
for chronic metabolic and cardiopulmonary conditions with
significant unmet medical needs. Utilizing its next generation
structure-based drug discovery platform, the Company has
established a scientifically-driven, GPCR-targeted pipeline,
featuring two wholly-owned proprietary clinical-stage small
molecule compounds designed to surpass the limitations of
traditional biologic and peptide therapies and be accessible to
more patients around the world. For additional information, please
visit www.structuretx.com.
Contacts:
Investors:Danielle KeatleyStructure
Therapeutics Inc.ir@structuretx.com
Media:Dan Budwick1ABDan@1abmedia.com
Structure Therapeutics (NASDAQ:GPCR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Structure Therapeutics (NASDAQ:GPCR)
Historical Stock Chart
From Apr 2023 to Apr 2024